PreTT ApS
PrivateLast Round
Grant
Feb 24, 2026
Total Funding Raised
$5.11M
Company Overview
PreTT ApS is a biotechnology company that develops pretargeted radioligand therapy platforms to improve the precision and effectiveness of cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreTT ApS Comparables
Compare PreTT ApS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoOne | 86% | |
| Akiram Therapeutics | 81% | |
| Tagworks Pharmaceuticals | 77% | |
PreTT ApS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 24, 2026 | ||||
| Grant | Apr 3, 2025 | ||||
| Accelerator | Feb 29, 2024 |
Key People
Founding team and executive leadership
PreTT ApS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Eurostars SME programme | Grant |
| BioInnovation Institute | Accelerator |
PreTT ApS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PreTT ApS's valuation, stock price, and market status.